These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1525956)

  • 1. Synthesis and antitumor activities of mitomycin C (1----3)-beta-D-glucan conjugate.
    Nagai K; Tanaka J; Kiho T; Ukai S
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):986-9. PubMed ID: 1525956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and antitumor activities of mitomycin C beta-(1-->6)-branched (1-->3)-beta-D-glucan conjugate.
    Usui S; Murashima K; Sakai M; Kiho T; Ukai S
    Biol Pharm Bull; 1994 Sep; 17(9):1165-70. PubMed ID: 7841935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan.
    Kasai S; Fujimoto S; Nitta K; Baba H; Kunimoto T
    J Pharmacobiodyn; 1991 Sep; 14(9):519-25. PubMed ID: 1779406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.
    Hashida M; Kato A; Kojima T; Muranishi S; Sezaki H; Tanigawa N; Satomura K; Hikasa Y
    Gan; 1981 Apr; 72(2):226-34. PubMed ID: 6169584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and antitumor activities of conjugates of mitomycin C-polysaccharide from Tremella fuciformis].
    Ukai S; Kiriki H; Nagai K; Kiho T
    Yakugaku Zasshi; 1992 Sep; 112(9):663-8. PubMed ID: 1469614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate.
    Song Y; Onishi H; Nagai T
    Biol Pharm Bull; 1993 Jan; 16(1):48-54. PubMed ID: 8369752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells.
    Morikawa K; Takeda R; Yamazaki M; Mizuno D
    Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen peroxide as a tumoricidal mediator of murine polymorphonuclear leukocytes induced by a linear beta-1,3-D-glucan and some other immunomodulators.
    Morikawa K; Kamegaya S; Yamazaki M; Mizuno D
    Cancer Res; 1985 Aug; 45(8):3482-6. PubMed ID: 2990672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo properties of the conjugates of mitomycin C with estradiol benzoate and estradiol: pharmacokinetics and antitumor characteristics against P388 leukemia and sarcoma 180.
    Ishiki N; Onishi H; Machida Y
    Biol Pharm Bull; 1998 Nov; 21(11):1180-6. PubMed ID: 9853409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
    Sato M; Onishi H; Takahara J; Machida Y; Nagai T
    Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products.
    Sasaki T; Abiko N; Sugino Y; Nitta K
    Cancer Res; 1978 Feb; 38(2):379-83. PubMed ID: 620409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysaccharides in fungi. XXXVII. Immunomodulating activities of carboxymethylated derivatives of linear (1-->3)-alpha-D-glucans extracted from the fruiting bodies of Agrocybe cylindracea and Amanita muscaria.
    Yoshida I; Kiho T; Usui S; Sakushima M; Ukai S
    Biol Pharm Bull; 1996 Jan; 19(1):114-21. PubMed ID: 8820922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
    Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
    Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans.
    Sasaki T; Abiko N; Uchida H; Tanaka M; Nitta K; Yoshioka Y; Nomura H
    Cancer Treat Rep; 1983 Mar; 67(3):275-80. PubMed ID: 6831473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the alternative pathway of complement by an antitumor (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140, and its lower molecular weight and carboxymethylated derivatives.
    Honda S; Sugino H; Asano T; Kakinuma A
    Immunopharmacology; 1986 Feb; 11(1):29-37. PubMed ID: 3957648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyldithio) ethyl] mitomycin C (BMY-25067).
    Bradner WT; Rose WC; Schurig JE; Florczyk AP
    Invest New Drugs; 1990; 8 Suppl 1():S1-7. PubMed ID: 2380013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
    Ohno N; Kurachi K; Yadomae T
    J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activities of conjugates of mitomycin C with estradiol benzoate and estradiol via glutaric acid in suspension dosage form.
    Ishiki N; Onishi H; Machida Y
    Biol Pharm Bull; 2002 Oct; 25(10):1373-7. PubMed ID: 12392099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of antitumor activity and immunomodulatory effect of tetrahydro-2-furanyl and tetrahydro-2-pyranyl (1 leads to 3)-beta-D-glucans.
    Uchida H; Sasaki T
    J Pharmacobiodyn; 1983 Sep; 6(9):660-7. PubMed ID: 6655547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice.
    Ashizawa T; Okamoto A; Okabe M; Kobayashi S; Arai H; Saito H; Kasai M; Gomi K
    Anticancer Drugs; 1995 Dec; 6(6):763-70. PubMed ID: 8845489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.